These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 214090)

  • 1. Inhibition cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist.
    Chasin M; Scott C
    Biochem Pharmacol; 1978; 27(16):2065-7. PubMed ID: 214090
    [No Abstract]   [Full Text] [Related]  

  • 2. Different sensitivites of cyclic nucleotide phosphodiesterases of rat brain and lung to inhibition by new anti-allergic chromones [proceedings].
    Saeed SA; Butt NM; Spicer JW; Warren BT
    Biochem Soc Trans; 1979 Dec; 7(6):1308-10. PubMed ID: 231533
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds.
    Ruckstuhl M; Landry Y
    Biochem Pharmacol; 1981 Apr; 30(7):697-702. PubMed ID: 6264919
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective inhibition of rat lung cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase by cyclic nucleotides and their analogues and various drugs [proceedings].
    Butt NM; Saeed SA; Collier HO
    Biochem Soc Trans; 1980 Jun; 8(3):380-1. PubMed ID: 6249674
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
    Glass WF; Moore JB
    Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of human lymphocyte cyclic nucleotide phosphodiesterases by the chlorinated adenosine analog DTA-35.
    Hurwitz MY; Hurwitz RL; Edstrom RD
    J Enzyme Inhib; 1987; 1(4):267-74. PubMed ID: 2854846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
    Nemoz G; Prigent AF
    Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
    Kass DA
    Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylxanthine inhibitors of phosphodiesterases.
    Wells JN; Miller JR
    Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
    Nicholson CD; Shahid M
    Pulm Pharmacol; 1994 Feb; 7(1):1-17. PubMed ID: 8003849
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the inhibition of phosphodiesterase-catalyzed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle.
    Polson JB; Krzanowski JJ; Fitzpatrick DF; Szentivanyi A
    Biochem Pharmacol; 1978 Jan; 27(2):254-6. PubMed ID: 203292
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung.
    Davis CW; Kuo JF
    Biochem Pharmacol; 1978 Jan; 27(1):89-95. PubMed ID: 202285
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological inhibition of calmodulin-sensitive phosphodiesterases.
    Ilien B; Ruckstuhl M; Landry Y
    J Pharmacol; 1982; 13(2):307-16. PubMed ID: 6285085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
    Sharma RV; Bhalla RC
    Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
    Némoz G; Prigent AF; Picq M; Pacheco H
    Biochem Pharmacol; 1982 Nov; 31(21):3353-8. PubMed ID: 6293510
    [No Abstract]   [Full Text] [Related]  

  • 16. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
    Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
    Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of polyphloretin phosphate (PPP) and quinterenol of cyclic nucleotide phosphodiesterase activities.
    Curtis-Prior PB; Chan YH
    Pharmacol Res Commun; 1981 Apr; 13(4):331-7. PubMed ID: 6270700
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic nucleotide phosphodiesterase activities of the embryonic chick ovary.
    Teng CT; Buchler B; Teng CS
    Gen Comp Endocrinol; 1981 Aug; 44(4):409-17. PubMed ID: 6167486
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 20. Flavonoids are selective cyclic GMP phosphodiesterase inhibitors.
    Ruckstuhl M; Beretz A; Anton R; Landry Y
    Biochem Pharmacol; 1979; 28(4):535-8. PubMed ID: 218594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.